A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis

Journal of Aerosol Medicine and Pulmonary Drug Delivery, Ahead of Print.

Source: Journal of Aerosol Medicine and Pulmonary Drug Delivery - January 30, 2019 Category: Respiratory Medicine Authors: Jun Keng Khoo A. Bruce Montgomery Kelly L. Otto Mark Surber Jessica Faggian Jason D. Lickliter Ian Glaspole Source Type: research